Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Mar Drugs ; 22(2)2024 Jan 31.
Article in English | MEDLINE | ID: mdl-38393047

ABSTRACT

Patients with ulcerative colitis (UC) have higher rates of depression. However, the mechanism of depression development remains unclear. The improvements of EPA and DHA on dextran sulfate sodium (DSS)-induced UC have been verified. Therefore, the present study mainly focused on the effects of EPA and DHA on UC-induced depression in C57BL/6 mice and the possible mechanisms involved. A forced swimming test and tail suspension experiment showed that EPA and DHA significantly improved DSS-induced depressive-like behavior. Further analysis demonstrated that EPA and DHA could significantly suppress the inflammation response of the gut and brain by regulating the NLRP3/ASC signal pathway. Moreover, intestine and brain barriers were maintained by enhancing ZO-1 and occludin expression. In addition, EPA and DHA also increased the serotonin (5-HT) concentration and synaptic proteins. Interestingly, EPA and DHA treatments increased the proportion of dominant bacteria, alpha diversity, and beta diversity. In conclusion, oral administration of EPA and DHA alleviated UC-induced depressive-like behavior in mice by modulating the inflammation, maintaining the mucosal and brain barriers, suppressing neuronal damage and reverting microbiota changes.


Subject(s)
Colitis, Ulcerative , Humans , Mice , Animals , Dextran Sulfate/toxicity , Mice, Inbred C57BL , Colitis, Ulcerative/metabolism , Signal Transduction , Inflammation/metabolism , Disease Models, Animal , Colon/metabolism
2.
Mol Nutr Food Res ; 63(5): e1800707, 2019 03.
Article in English | MEDLINE | ID: mdl-30512229

ABSTRACT

SCOPE: Cerebrosides are a class of neutral glycosphingolipids, which are widely found to be present in brain tissue. In this study, the protective effect of sea cucumber cerebrosides (Cer) against ß-amyloid (Aß)-induced cognitive impairment is investigated. METHODS AND RESULTS: Male SD rats receive a ventricle injection Aß1-42 peptide to establish an Alzheimer's disease model. Then, the protective effects of Cer against Aß1-42 -induced cognitive impairment by gavage and feed addition are evaluated. The Morris water maze test results show that oral administration of Cer can significantly ameliorate Aß1-42 -induced cognitive deficiency at both high dose (200 mg per kg·per day) and low dose (40 mg per kg·per day) for 27 days. Dietary supplement of Cer by feed addition also exhibits the amelioration on the impaired cognitive function. Further findings indicate that Cer ameliorates Aß1-42 -induced neuronal damage and suppresses the induced apoptosis by decreasing the level of Bax/Bcl-2. Additionally, Cer enhances the expressions of PSD-95 and synaptophysin by activating BDNF/TrkB/CREB signaling pathway, thereby ameliorating Aß1-42 -induced synaptic dysfunction. Furthermore, Cer attenuates Aß1-42 -induced tau hyperphosphorylation by activating the PI3K/Akt/GSK3ß signaling pathway. CONCLUSION: Sea cucumber cerebrosides possess neuroprotective effects against Aß1-42 -triggered cognitive deficits, which may be a potential nutritional preventive strategy for neurodegenerative diseases.


Subject(s)
Alzheimer Disease/etiology , Cerebrosides/pharmacology , Cognition Disorders/drug therapy , Hippocampus/drug effects , Sea Cucumbers/chemistry , Administration, Oral , Amyloid beta-Peptides/toxicity , Animals , Apoptosis/drug effects , Cerebrosides/administration & dosage , Cognition Disorders/chemically induced , Cognition Disorders/diet therapy , Dietary Supplements , Hippocampus/cytology , Hippocampus/pathology , Learning/drug effects , Male , Neurons/drug effects , Neuroprotective Agents/pharmacology , Peptide Fragments/toxicity , Phosphorylation/drug effects , Rats, Sprague-Dawley , tau Proteins/metabolism
3.
J Nutr Biochem ; 59: 64-75, 2018 09.
Article in English | MEDLINE | ID: mdl-29986309

ABSTRACT

Recent studies have shown that a high-fat diet (HFD) is involved in both metabolic dysfunction and cognitive deficiency and that docosahexaenoic-acid-enriched phospholipids (DHA-PLs) have beneficial effects on obesity and cognitive impairment. However, there are only a few studies comparing differences between DHA-PC and DHA-PS in HFD-induced Alzheimer's disease (AD) models. After 8 weeks feeding with HFD, 10-month-old SAMP8 mice were fed with 1% (w/w) DHA-PC or 1% DHA-PS (biosynthesized from DHA-PC) for 8 weeks; we then tested the behavioral performances in the Barnes maze test and Morris maze test. The changes of the generation and accumulation of Aß, oxidative stress, apoptosis, neuroinflammation and neurotrophic factors were also measured. The results indicated that both DHA-PC and DHA-PS significantly improved the metabolic disorders and cognitive deficits. Both DHA-PC and DHA-PS could ameliorate oxidative stress, and DHA-PS presented more notable benefits than DHA-PC on Aß pathology, mitochondrial damage, neuroinflammation and neurotrophic factors; DHA-PS was for the first time found to increase the production of insoluble Aß (less pathogenic) in this AD model. These data suggest that DHA-PLs can significantly improve cognitive deficiency, and the molecular mechanisms for this closely relate to the phospholipid polar groups.


Subject(s)
Aging/physiology , Cognitive Dysfunction/diet therapy , Diet, High-Fat/adverse effects , Docosahexaenoic Acids/pharmacology , Phospholipids/pharmacology , Aging/drug effects , Amyloid beta-Peptides/metabolism , Animals , Apoptosis/drug effects , Body Weight/drug effects , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Cerebral Cortex/pathology , Cognitive Dysfunction/etiology , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/pathology , Male , Mice, Mutant Strains , Neuroprotective Agents/pharmacology , Oxidative Stress/drug effects , Phosphatidylcholines/chemistry , Phosphatidylcholines/pharmacology , Phosphatidylserines/chemistry , Phosphatidylserines/pharmacology , Phospholipids/chemistry , Phospholipids/metabolism
4.
Mol Nutr Food Res ; 62(7): e1700637, 2018 04.
Article in English | MEDLINE | ID: mdl-29396909

ABSTRACT

SCOPE: Recent studies have shown that omega-3 PUFAs enriched phospholipids (n-3 PUFA-PLs) have beneficial effects on memory and cognition. However, most reports only attribute the benefit to docosahexaenoic acid (DHA) and pay little attention to eicosapentaenoic acid (EPA). METHODS AND RESULTS: We investigate the effect of EPA-enriched phospholipids on cognitive deficiency in senescence-accelerated prone 8 (SAMP8) mouse. Ten-month-old SAMP8 mice are fed with 2% (w/w) EPA-enriched phosphatidylcholine/phosphatidyl ethanolamine (EPA-PC/PE; EPA:DHA = 46.8:3.01) or 2% EPA-enriched phosphatidylserine (EPA-PS; biosynthesized from EPA-PC/PE) for 8 weeks; we then test the behavioral performances in the Barnes maze test and Morris maze test; the changes of oxidative stress, apoptosis, neurotrophic factors, tau phosphorylation, and Aß pathology are also measured. The results of behavior tests indicate that both EPA-PC/PE and EPA-PS significantly improve memory and cognitive deficiency. It is found that remarkable amelioration of oxidative stress and apoptosis occurs in both EPA-PC/PE and EPA-PS groups. EPA-PS shows more ameliorative effects than EPA-PC/PE on neurotrophic activity by decreasing hyper-phosphorylation of tau and depressing the generation and accumulation of ß-amyloid peptide (Aß). CONCLUSION: These data suggest that EPA-PS exhibits better effects than EPA-PC/PE on ameliorating memory and cognitive function, which might be attributed to the phospholipid polar groups.


Subject(s)
Aging , Cognitive Dysfunction/prevention & control , Dietary Supplements , Eicosapentaenoic Acid/therapeutic use , Memory Disorders/prevention & control , Nootropic Agents/therapeutic use , Phospholipids/therapeutic use , Animals , Apoptosis , Behavior, Animal , Brain/metabolism , Calceolariaceae/chemistry , Gene Expression Regulation, Developmental , Male , Mice , Mice, Mutant Strains , Nerve Tissue Proteins/genetics , Nerve Tissue Proteins/metabolism , Neurons/metabolism , Oxidative Stress , Phosphatidylcholines/therapeutic use , Phosphatidylethanolamines/therapeutic use , Phosphatidylserines/therapeutic use , Random Allocation
5.
Lipids Health Dis ; 16(1): 234, 2017 Dec 08.
Article in English | MEDLINE | ID: mdl-29216887

ABSTRACT

BACKGROUND: Docosahexaenoic acid (DHA) is important for optimal neurodevelopment and brain function during the childhood when the brain is still under development. METHODS: The effects of DHA-Phosphatidylcholine (DHA-PC) and the recombination of DHA-Triglyceride with egg PC (DHA-TG + PC) or α-Glycerylphosphorylcholine (DHA-TG + α-GPC) were comparatively analyzed on DHA recovery and the DHA accumulation kinetics in tissues including cerebral cortex, erythrocyte, liver, and testis were evaluated in the weaning n-3 deficient mice. RESULTS: The concentration of DHA in weaning n-3 deficient mice could be recovered rapidly by dietary DHA supplementation, in which DHA-PC exhibited the better efficacy than the recombination of DHA-Triglyceride with egg PC or α-GPC. Interestingly, DHA-TG + α-GPC exhibited the greater effect on DHA accumulation than DHA-TG + PC in cerebral cortex and erythrocyte (p < 0.05), which was similar to DHA-PC. Meanwhile, DHA-TG + PC showed a similar effect to DHA-PC on DHA repletion in testis, which was better than that of DHA-TG + α-GPC (p < 0.05). CONCLUSION: We concluded that different forms of DHA supplements could be applied targetedly based on the DHA recovery in different tissues, although the supplemental effects of the recombination of DHA-Triglyceride with egg PC or α-GPC were not completely equivalent to that of DHA-PC, which could provide some references to develop functional foods to support brain development and function.


Subject(s)
Dietary Supplements , Docosahexaenoic Acids/administration & dosage , Fatty Acids, Omega-3/deficiency , Glycerylphosphorylcholine/administration & dosage , Phosphatidylcholines/administration & dosage , Triglycerides/administration & dosage , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Chickens , Docosahexaenoic Acids/chemistry , Docosahexaenoic Acids/metabolism , Eggs/analysis , Erythrocytes/drug effects , Erythrocytes/metabolism , Glycerylphosphorylcholine/chemistry , Liver/drug effects , Liver/metabolism , Male , Mice , Mice, Inbred ICR , Organ Specificity , Phosphatidylcholines/chemistry , Testis/drug effects , Testis/metabolism , Tissue Distribution , Triglycerides/chemistry , Weaning
6.
J Zhejiang Univ Sci B ; 16(8): 672-9, 2015 Aug.
Article in English | MEDLINE | ID: mdl-26238542

ABSTRACT

Traditional methods for detecting lactoperoxidase (LP) are complex and time-consuming, so a test strip was made based on the enzymatic reaction principle to enable quick and convenient detection of LP in raw milk. In this study 0.1 mol/L citric acid (CA)/0.2 mol/L disodium hydrogen phosphate (NaP) buffer solution (pH 5.0), 22 mmol/L 3,3',5,5'-tetramethylbenzidine (TMB), 0.6 mmol/L hydrogen peroxide (H2O2), and 0.5% Tween-20 or 0.3% cetyltrimethyl ammonium bromide (CTAB) were optimal for preparing a quick, sensitive, and accurate LP test strip. The coefficient of variation (CV) of the estimated LP concentrations ranged from 2.47% to 6.72% and the minimum LP concentration detected by the test strip was 1-2 mg/L. Estimates of active LP in sixteen raw milk samples obtained using the test strip or the TMB method showed a good correlation (r=0.9776). So the test strip provides a quick, convenient, and accurate method for detecting the LP concentration of raw milk.


Subject(s)
Disposable Equipment , Food Analysis/instrumentation , Food Contamination/analysis , Lactoperoxidase/analysis , Milk/chemistry , Reagent Strips , Animals , Chromatography, Paper/instrumentation , Chromogenic Compounds/chemistry , Equipment Design , Equipment Failure Analysis , Pasteurization , Reproducibility of Results , Sensitivity and Specificity
7.
J Zhejiang Univ Sci B ; 15(2): 143-52, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24510707

ABSTRACT

This study investigated the effect of heat treatment combined with acid and alkali on the angiotensin-I-converting enzyme (ACE) inhibitory activity of peptides derived from bovine casein. The free amino group content, color, and cytotoxicity of the peptides were measured under different conditions. When heated at 100 °C in the pH range from 9.0 to 12.0, ACE inhibitory activity was reduced and the appearance of the peptides was significantly darkened. After thermal treatment in the presence of acid and alkali, the free amino group content of ACE inhibitory peptides decreased markedly. High temperature and prolonged heating also resulted in the loss of ACE inhibitory activity, the loss of free amino groups, and the darker coloration of bovine casein-derived peptides. However, ACE inhibitory peptides, within a concentration range of from 0.01 to 0.2 mg/ml, showed no cytotoxicity to Caco-2 and ECV-304 cell lines after heat treatment. This indicated that high temperature and alkaline heat treatment impaired the stability of bovine casein-derived ACE inhibitory peptides.


Subject(s)
Angiotensin-Converting Enzyme Inhibitors/chemistry , Caseins/chemistry , Peptides/chemistry , Peptidyl-Dipeptidase A/chemistry , Animals , Caco-2 Cells , Cattle , Cell Line, Tumor , Cell Survival , Hot Temperature , Humans , Hydrogen-Ion Concentration , Hydrolysis
SELECTION OF CITATIONS
SEARCH DETAIL
...